Artificial Intelligence in Early Diagnosis of Neurodegenerative Disorders: A Systematic Review of Clinical Applications and Challenges

Neurodegenerative diseases like Alzheimer's disease (AD) and Parkinson's disease (PD) are irreversible disorders of a progressive nature. Early diagnosis, which helps early intervention, leads to a longer, healthier life. Conventional modalities of diagnosis are usually insensitive at an early phase. Artificial Intelligence (AI) is a trend that promises to identify such subtle pathological patterns in data of various modalities. The purpose of this systematic review is to assess the ability of AI-based tools to detect neurodegenerative disorders in the early stages, identify their synergy with clinical practice, and reveal current gaps. The literature search was based on the use of several databases and other resources, resulting in 328 unique records. The screening, followed by an assessment of eligibility based on PRISMA, revealed 12 primary studies. R was applied to perform a meta-analysis to estimate a pooled AUC and determine the heterogeneity. Publication bias was analysed by funnel plots and formal tests. The respective studies leverage techniques of AI, which include support vector machines and deep neural networks, and evaluate data types that include MRI, blood biomarkers, speech, and wearable sensors. The AUC pooled was 0.90 (95% CI: 0.88-0.91), implying great diagnostic precision. Substantial heterogeneity was experienced (I² = 30.3%). Research combining multimodal data and hybrid AI strategies produced the greatest results. There was only a little publication bias, as detailed in the funnel plot symmetry and statistical tests. Tools realised through AI illustrate strong diagnostic capabilities of neurodegenerative illnesses at an early stage. Nonetheless, additional external confirmation, long-term findings, and interpretability are required to be used clinically. Artificial intelligence (AI) can aid conventional diagnostics, leading to earlier and more exact interventions.

Authors

Institutions

Publication Details

Journal
International journal of medical and health research.
Published
2025-08-22
DOI
https://doi.org/10.61424/ijmhr.v3i3.382
Primary Topic
Cerebrovascular and genetic disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial Intelligence in Early Diagnosis of Neurodegenerative Disorders: A Systematic Review of Clinical Applications and Challenges

M. S. Raña, Adil Riaz, Francesco Ernesto Alessi Longa, Opeyemi Sheu Alamu
International journal of medical and health research.
Cerebrovascular and genetic disorders
article

Artificial Intelligence in Early Diagnosis of Neurodegenerative Disorders: A Systematic Review of Clinical Applications and Challenges

M. S. Raña, Adil Riaz, Francesco Ernesto Alessi Longa, Opeyemi Sheu Alamu
article en

Abstract

Neurodegenerative diseases like Alzheimer's disease (AD) and Parkinson's disease (PD) are irreversible disorders of a progressive nature. Early diagnosis, which helps early intervention, leads to a longer, healthier life. Conventional modalities of diagnosis are usually insensitive at an early phase. Artificial Intelligence (AI) is a trend that promises to identify such subtle pathological patterns in data of various modalities. The purpose of this systematic review is to assess the ability of AI-based tools to detect neurodegenerative disorders in the early stages, identify their synergy with clinical practice, and reveal current gaps. The literature search was based on the use of several databases and other resources, resulting in 328 unique records. The screening, followed by an assessment of eligibility based on PRISMA, revealed 12 primary studies. R was applied to perform a meta-analysis to estimate a pooled AUC and determine the heterogeneity. Publication bias was analysed by funnel plots and formal tests. The respective studies leverage techniques of AI, which include support vector machines and deep neural networks, and evaluate data types that include MRI, blood biomarkers, speech, and wearable sensors. The AUC pooled was 0.90 (95% CI: 0.88-0.91), implying great diagnostic precision. Substantial heterogeneity was experienced (I² = 30.3%). Research combining multimodal data and hybrid AI strategies produced the greatest results. There was only a little publication bias, as detailed in the funnel plot symmetry and statistical tests. Tools realised through AI illustrate strong diagnostic capabilities of neurodegenerative illnesses at an early stage. Nonetheless, additional external confirmation, long-term findings, and interpretability are required to be used clinically. Artificial intelligence (AI) can aid conventional diagnostics, leading to earlier and more exact interventions.

International journal of medical and health research.Vol. 3(3)
University of Azad Jammu and Kashmir (PK), Universidad Azteca (MX), Department of Animal Health (VN), Royal University of Bhutan (BT)
Openalex Percentile: Top 68%
Cerebrovascular and genetic disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.